Global Point of Care Molecular Diagnostics Market By Type (Polymerase Chain Reaction (Real Time PCR), In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, and Others), By Application (Hospitals, Diagnostic Laboratories, and Research & Academic Laboratories), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 139386
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Point of Care Molecular Diagnostics Market is estimated to be valued US$ XX.X million in 2019. The report on Point of Care Molecular Diagnostics Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global point of care molecular diagnostics market is segmented on the basis of Type, Application, and geography.
In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.
Point of Care Molecular Diagnostics Market Scope:
By type, the market is segmented into Polymerase Chain Reaction (Real Time PCR), In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, and Others. By Application, the market is divided into Hospitals, Diagnostic Laboratories, and Research & Academic Laboratories.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bayer Corporation, Roche Diagnostics, Sysmex Corporation, Abaxis, Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, and OraSure Technologies.Key Market Segments
Type
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Key Market Players included in the report:
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Point of Care Molecular Diagnostics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Point of Care Molecular Diagnostics Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Point of Care Molecular Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Point of Care Molecular Diagnostics Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Point of Care Molecular Diagnostics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Point of Care Molecular Diagnostics Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Point of Care Molecular Diagnostics sub-markets, depending on key regions (various vital states).
To analyze Point of Care Molecular Diagnostics Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Point of Care Molecular Diagnostics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Point of Care Molecular Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Point of Care Molecular Diagnostics Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Point of Care Molecular Diagnostics Market Overview
3.1. Point of Care Molecular Diagnostics Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Point of Care Molecular Diagnostics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Point of Care Molecular Diagnostics Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Polymerase Chain Reaction (Real Time PCR)4.4. In Situ Hybridization
4.5. Chips and Microarrays
4.6. Mass Spectrometry
4.7. Sequencing
4.8. Isothermal Amplification
4.9. Others
5. Global Point of Care Molecular Diagnostics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Point of Care Molecular Diagnostics Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Hospitals5.4. Diagnostic Laboratories
5.5. Research & Academic Laboratories
6. Global Point of Care Molecular Diagnostics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Point of Care Molecular Diagnostics Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Point of Care Molecular Diagnostics Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Point of Care Molecular Diagnostics Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Point of Care Molecular Diagnostics Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Point of Care Molecular Diagnostics Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global Point of Care Molecular Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Bayer Corporation7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Roche Diagnostics
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Sysmex Corporation
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Abaxis
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Abbott Laboratories
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. BioMerieux SA
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Bio-Rad Laboratories
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Danaher Corporation
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. OraSure Technologies
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
